论文部分内容阅读
应用免疫疗法治疗慢性肝炎,是探索治疗慢性肝炎的一个重要途径。我们自1975年11月～1976年11月试以正常人周围血白细胞和脾血白细胞中提取的免疫核糖核酸(下称iRNA)治疗慢性乙型肝炎28例,观察其能否提高患者细胞免疫功能,从而达到改善症状、体征和肝功能等,使病情稳定或恢复,甚至达到HB_sAg转阴。现将研究初步结果报告如下。一、病例选择本组28例中,慢性活动性肝炎7例,慢性迁延性肝炎21例。男15例,女13例。年龄最小16岁,最大60岁。病程除2例各为9和10个月外,余均超过一年。上述病例在用
The application of immunotherapy for chronic hepatitis is an important way to explore the treatment of chronic hepatitis. We from November 1975 to November 1976 try to normal peripheral blood leukocytes and spleen white blood cells extracted from the immune ribonucleic acid (hereinafter referred to as iRNA) treatment of chronic hepatitis B in 28 cases to observe whether it can improve cellular immune function , So as to improve the symptoms, signs and liver function, so that the condition is stable or recovery, or even negative HB_sAg. The preliminary results of the study are reported below. First, the case selection of 28 cases, chronic active hepatitis in 7 cases, chronic persistent hepatitis in 21 cases. 15 males and 13 females. Youngest 16 years old, maximum 60 years old. In addition to 2 cases of disease duration of 9 and 10 months, I have more than a year. The above cases are in use